Cardiovascular Risk Factors and Total Serum Antioxidant Capacity in Healthy Men and in Men with Coronary Heart Disease

Table 1

Age, selected anthropometric and biochemical characteristics, cigarette smoking, blood pressure, and total antioxidant capacity in men with CHD and in their peers without CHD.

Variable	Group I; (CHD patients)	Group II; (without CHD)
Age (years)	56.59 ± 8.04	56.66 ± 7.99
Body mass (kg)	85.4 ± 13.5	83.0 ± 13.1
BMI (kg·m^−2)		27.1 ± 3.8
Waist circumference (cm)		94.9 ± 10.1
WHR		0.94 ± 0.06
Percentage of body fat		23.6 ± 5.8
Past smokers (% of )		56.4
Current smokers (% of )	13	13
SBP (mmHg)	127.3 ± 14.7	127.8 ± 13.9
DBP (mmHg)	81.9 ± 9.1	82.6 ± 9.3
TC (mg·dL^−1)		217.1 ± 43.2
LDL-C (mg·dL^−1)		142.6 ± 40.6
HDL-C (mg·dL^−1)		50.7 ± 11.6
TC/HDL-C ratio		4.48 ± 1.3
TG (mg·dL^−1)		125.6 ± 85.2
Glucose (mg·dL^−1)	100.1 ± 30.1	99.3 ± 21.1
UA (mg·dL^−1)	6.13 ± 1.35	5.98 ± 1.23
TAC-FRAS (mmol FeCl2·L^−1)		1.26 ± 0.26
TAC-DPPH (% reduction)		11.2 ± 4.4

, , and as compared to the healthy subjects.
BMI: body mass index; WHR: waist-to-hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; TG: triglycerides; UA: uric acid; TAC: total antioxidant capacity; FRAS: ferric reducing ability of serum; DPPH: 2.2-diphenyl-1-picryl-hydrazyl; CHD: coronary heart disease.